beta
Trial Radar AI

Showing clinical trials for Diabetes, Hyperglycemia, Type 1 Diabetes.

I can help you find nearby clinical trials and understand health conditions and treatments.
32 Results
 
Condition
Diabetes, Hyperglycemia, Type 1 Diabetes
×
 
Keywords
Continuous Glucose Monitoring
×
 
Biological Sex
All
×
 
Study Title
Status
Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge NCT06852950
Recruiting
Continuous Glucose Monitoring Initiation at Hospital Discharge (CGM4Home) NCT04854135
TerminatedResults Posted
CGM Use in Poorly Controlled Youth With Type 1 Diabetes (IMPaCT) NCT04721145
CompletedResults Posted
Safety and Efficacy of RT-CGMS in Patients With Type 1 Diabetes Mellitus Treated With an Implantable Pump (IP_RT-CGMS) NCT00501072
Completed
FAM (Follower, Action Plan, and Remote Monitoring) Intervention to Reduce Severe Hyperglycemia in Adults With Type 1 Diabetes Mellitus at Risk for Diabetic Ketoacidosis NCT06114186
Completed
Effects of Capros in Patients With Type-1 Diabetes (CarposT1D) NCT02634216
Completed
Continuous Correction NCT02162004
Terminated
Continuous Monitoring of Glycemic Variability to Predict Dys- and Hyperglycemia in Asymptomatic Type 1 Diabetes NCT05777330
Recruiting
Effectiveness of Aerobic Exercise to Mitigate Hyperglycemia After Fasted Resistance Exercise NCT05203653
Completed
Early Glargine (Lantus) in DKA Management in Children With Type 1 Diabetes NCT03107208
CompletedResults Posted
mRNA Based-Covid-19 Vaccine Effects on Blood Glucose Levels NCT04923386
Completed
The Efficacy and Safety of Faster Insulin Aspart (Fiasp®) Compared to Conventional Insulin Aspart (NovoLog®) as Correction Bolus (PLATEAU) NCT04414579
Unknown status
Neurocognitive Performance During Hyperglycemia , and Brain Tissue Integrity in Youth With Type 1 Diabetes and in Healthy (T1DM) NCT02923323
Unknown status
Type 1 Diabetic Post Prandial Glycemia Evaluation Using an Algorithm (EGHYA) NCT05151770
Completed
Impact of MEnstruation on Glycemic Response and Exercise In Females With Type 1 Diabetes (MERIT) NCT06297980
Recruiting
GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Glucose Monitoring (CGM) by Using FreeStyle Libre 2 (FSL2) for Preventing Hyperglycemia/Hypoglycemia Crisis in Advanced Oncological Patients. NCT04942756
Unknown status
Feasibility Study Assessing The Ability Of An Insulin Pump-Controlling Algorithm To Minimize Hypoglycemia And Hyperglycemia In Patients With Type 1 Diabetes In A Clinical Research Setting NCT01401751
Completed
Telemetric Glucose Data Acquisition During Initiation of Insulin Pump Therapy NCT00297635
Withdrawn
Safety and Feasibility Evaluation of the APS APP NCT03504046
Completed
Insulin and Abatacept in Recently-diagnosed Type 1 Diabetes (IAA) NCT05742243
Completed
At Home Study of a Zone-Model Predictive Control (MPC) Controller and a Health Monitoring System (HMS) With the Diabetes Assistant (DiAs) System and Run-to-Run Adaptation NCT02705053
Completed
Model Predictive Control (MPC) Artificial Pancreas vs. Sensor Augmented Pump (SAP)/Predictive Low Glucose Suspend (PLGS) With Different Food Choices in the Outpatient Setting NCT03767790
Completed
CGM Utilization With IV Insulin EndoTool and Subcutaneous Insulin in the Neuro ICU NCT05857007
Completed
Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes NCT00434850
Completed
Stimulated Glucagon as a Biomarker of Hypoglycemic Risk in Type 1 Diabetes (MUGGLE) NCT05616273
Completed
The SHINE Study: Safety of Implant and Preliminary Performance of the SHINE SYSTEM in Diabetic Subjects NCT05597605
Completed
Development of Agents to Diminish the Risk of Hypoglycemia-induced Brain Injury in Type 1 Diabetes NCT03356457
Completed
Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes NCT07167693
Recruiting
Closed-loop Insulin Delivery in the General Ward (ANGIE02) NCT01774565
Completed
Standardized Italian netwoRk Enrolling iNdividuals With Islet-Autoantibodies (SIRENA) NCT07503366
Not yet recruiting
Liraglutide in Type 1 Diabetes NCT01612468
Completed
Safety, Tolerability and Efficacy of Immunomodulation With AT-1501 in Islet Cell Transplantation NCT04711226
Withdrawn